Pacer Advisors, Inc. Inovio Pharmaceuticals, Inc. Transaction History

Pacer Advisors, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$6.23 - $10.03 $46,245 - $74,452	-7,423 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$8.81 - $16.96 $40,032 - $77,066	-4,544 Reduced 37.97%	7,423 $69,000
Q4 2020 Jan 20, 2021	BUY	$8.5 - $12.85 $33,099 - $50,037	3,894 Added 48.23%	11,967 $106,000
Q3 2020 Oct 19, 2020	BUY	$9.57 - $27.05 $77,258 - $218,374	8,073 New	8,073 $94,000
Q4 2018 Feb 13, 2019	SELL	$3.89 - $6.11 $34,854 - $54,745	-8,960 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$3.92 - $5.58 $35,123 - $49,996	8,960 New	8,960 $50,000
Q1 2018 May 14, 2018	SELL	$4.05 - $5.69 $13,972 - $19,630	-3,450 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$4.13 - $6.68 $14,248 - $23,046	3,450	3,450 $14,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $521M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.